Published in Biophys J on August 10, 2007
Binding modes of diketo-acid inhibitors of HIV-1 integrase: a comparative molecular dynamics simulation study. J Mol Graph Model (2011) 0.85
Raltegravir: molecular basis of its mechanism of action. Eur J Med Res (2009) 0.82
VMD: visual molecular dynamics. J Mol Graph (1996) 117.02
All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B (1998) 54.00
Integrase inhibitors to treat HIV/AIDS. Nat Rev Drug Discov (2005) 4.46
Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes. Proc Natl Acad Sci U S A (2002) 3.40
Solvent effects on protein motion and protein effects on solvent motion. Dynamics of the active site region of lysozyme. J Mol Biol (1989) 3.37
Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc Natl Acad Sci U S A (1998) 2.98
Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc Natl Acad Sci U S A (1999) 2.69
Discovery of a novel binding trench in HIV integrase. J Med Chem (2004) 2.09
Structure and function of HIV-1 integrase. Curr Top Med Chem (2004) 1.74
Active site dynamics of ribonuclease. Proc Natl Acad Sci U S A (1985) 1.65
Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity. J Biol Chem (1997) 1.47
On possible pitfalls in ab initio quantum mechanics/molecular mechanics minimization approaches for studies of enzymatic reactions. J Phys Chem B (2005) 1.37
Metal-dependent inhibition of HIV-1 integrase by beta-diketo acids and resistance of the soluble double-mutant (F185K/C280S). Mol Pharmacol (2003) 1.22
Mechanisms of antibiotic resistance: QM/MM modeling of the acylation reaction of a class A beta-lactamase with benzylpenicillin. J Am Chem Soc (2005) 1.18
Discovery of a small-molecule HIV-1 integrase inhibitor-binding site. Proc Natl Acad Sci U S A (2006) 1.16
Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors. Bioorg Med Chem (2006) 1.16
Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: implication for binding to two metal ions on the active site of integrase. J Med Chem (2004) 1.10
A combined QM/MM approach to protein--ligand interactions: polarization effects of the HIV-1 protease on selected high affinity inhibitors. J Med Chem (2004) 1.08
Fully flexible low-mode docking: application to induced fit in HIV integrase. J Am Chem Soc (2001) 1.06
Molecular dynamics studies on the HIV-1 integrase catalytic domain. Biophys J (1999) 1.06
Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants. Biophys J (2005) 1.04
Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors. J Med Chem (2005) 1.04
Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action. J Med Chem (2006) 1.03
Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase. J Med Chem (2005) 1.01
Ordered water and ligand mobility in the HIV-1 integrase-5CITEP complex: a molecular dynamics study. J Med Chem (2001) 1.00
From ligand to complexes: inhibition of human immunodeficiency virus type 1 integrase by beta-diketo acid metal complexes. J Med Chem (2006) 0.99
A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors. Bioorg Med Chem (2006) 0.96
Target recognition by catechols and beta-ketoenols: potential contribution of hydrogen bonding and Mn/Mg chelation to HIV-1 integrase inhibition. J Med Chem (2007) 0.96
Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase. J Med Chem (2005) 0.90
Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I/M154I catalytic domain. Biophys J (2005) 0.88
Spectroscopic studies of diketoacids-metal interactions. A probing tool for the pharmacophoric intermetallic distance in the HIV-1 integrase active site. J Med Chem (2004) 0.86
Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors. J Med Chem (2005) 0.85
Comparative molecular dynamics simulations of HIV-1 integrase and the T66I/M154I mutant: binding modes and drug resistance to a diketo acid inhibitor. Proteins (2005) 0.85
Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors. J Med Chem (2005) 0.85
Beta-diketo acids with purine nucleobase scaffolds: novel, selective inhibitors of the strand transfer step of HIV integrase. Bioorg Med Chem Lett (2006) 0.84
Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance. Biophys J (2003) 0.84
HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors. Bioorg Med Chem Lett (2004) 0.82
Active site binding modes of the beta-diketoacids: a multi-active site approach in HIV-1 integrase inhibitor design. Bioorg Med Chem (2004) 0.81
Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors. J Med Chem (2004) 0.81
Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase. Bioorg Med Chem (2006) 0.79
Active site dynamics and combined quantum mechanics/molecular mechanics (QM/MM) modelling of a HIV-1 reverse transcriptase/DNA/dTTP complex. J Mol Graph Model (2006) 0.78
Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling. J Med Chem (2009) 1.28
Charge-charge interactions are key determinants of the pK values of ionizable groups in ribonuclease Sa (pI=3.5) and a basic variant (pI=10.2). J Mol Biol (2003) 1.26
Molecular dissection of a critical specificity determinant within the amino acid editing domain of leucyl-tRNA synthetase. Biochemistry (2004) 1.11
The 1.9 A crystal structure of alanine racemase from Mycobacterium tuberculosis contains a conserved entryway into the active site. Biochemistry (2005) 1.11
Prediction of HIV-1 integrase/viral DNA interactions in the catalytic domain by fast molecular docking. J Med Chem (2004) 1.04
Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants. Biophys J (2005) 1.04
How amantadine and rimantadine inhibit proton transport in the M2 protein channel. J Mol Graph Model (2008) 1.02
Brownian dynamics simulations of the recognition of the scorpion toxin P05 with the small-conductance calcium-activated potassium channels. J Mol Biol (2002) 1.02
Brownian dynamics simulations of the recognition of the scorpion toxin maurotoxin with the voltage-gated potassium ion channels. Biophys J (2002) 1.00
An n-channel two-dimensional covalent organic framework. J Am Chem Soc (2011) 0.99
Insights into saquinavir resistance in the G48V HIV-1 protease: quantum calculations and molecular dynamic simulations. Biophys J (2004) 0.97
Electrostatic steering at acetylcholine binding sites. Biophys J (2006) 0.94
On the lower susceptibility of oseltamivir to influenza neuraminidase subtype N1 than those in N2 and N9. Biophys J (2006) 0.91
Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction. J Mol Recognit (2010) 0.90
Binding mode prediction of biologically active compounds from plant Salvia Miltiorrhiza as integrase inhibitor. Bioinformation (2013) 0.89
Computed pore potentials of the nicotinic acetylcholine receptor. Biophys J (2006) 0.89
Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors. J Med Chem (2005) 0.89
Nucleotide modification at the gamma-phosphate leads to the improved fidelity of HIV-1 reverse transcriptase. Nucleic Acids Res (2005) 0.89
A structure-based design approach for the identification of novel inhibitors: application to an alanine racemase. J Comput Aided Mol Des (2002) 0.88
Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I/M154I catalytic domain. Biophys J (2005) 0.88
Molecular modeling study of the editing active site of Escherichia coli leucyl-tRNA synthetase: two amino acid binding sites in the editing domain. Proteins (2004) 0.87
pK values of histidine residues in ribonuclease Sa: effect of salt and net charge. J Mol Biol (2003) 0.86
Source of high pathogenicity of an avian influenza virus H5N1: why H5 is better cleaved by furin. Biophys J (2008) 0.86
Comparative molecular dynamics simulations of HIV-1 integrase and the T66I/M154I mutant: binding modes and drug resistance to a diketo acid inhibitor. Proteins (2005) 0.85
Structure, dynamics and solvation of HIV-1 protease/saquinavir complex in aqueous solution and their contributions to drug resistance: molecular dynamic simulations. J Chem Inf Model (2005) 0.84
The association between a negatively charged ligand and the electronegative binding pocket of its receptor. Biopolymers (2002) 0.84
Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance. Biophys J (2003) 0.84
Molecular docking and 3D-QSAR studies on gag peptide analogue inhibitors interacting with human cyclophilin A. J Med Chem (2002) 0.84
Dynamic pharmacophore model optimization: identification of novel HIV-1 integrase inhibitors. J Med Chem (2006) 0.83
Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations. Biophys J (2007) 0.83
Molecular dynamics studies of alanine racemase: a structural model for drug design. Biopolymers (2003) 0.82
HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors. Bioorg Med Chem Lett (2004) 0.82
Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior. J Neurosci (2013) 0.81
Cluster analysis of water molecules in alanine racemase and their putative structural role. Protein Eng Des Sel (2004) 0.81
Modulation of substrate specificity within the amino acid editing site of leucyl-tRNA synthetase. Biochemistry (2007) 0.81
Computational insights into the interaction of the anthrax lethal factor with the N-terminal region of its substrates. Proteins (2009) 0.80
Mechanistic role of NS4A and substrate in the activation of HCV NS3 protease. Proteins (2011) 0.80
Receptor-based pharmacophore and pharmacophore key descriptors for virtual screening and QSAR modeling. Curr Comput Aided Drug Des (2011) 0.78
Theoretical investigations on the stereoselectivity of the proline catalyzed Mannich reaction in DMSO. J Org Chem (2008) 0.77
Charge-charge interactions are the primary determinants of the pK values of the ionizable groups in Ribonuclease T1. Biophys Chem (2002) 0.77
Interactions of acetylcholine binding site residues contributing to nicotinic acetylcholine receptor gating: role of residues Y93, Y190, K145 and D200. J Mol Graph Model (2013) 0.77
Simultaneous analysis of ultrafast fluorescence decays of FMN binding protein and its mutated proteins by molecular dynamic simulation and electron transfer theory. J Phys Chem B (2008) 0.77
The C-terminal region of xylanase domain in Xyn11A from Paenibacillus curdlanolyticus B-6 plays an important role in structural stability. Appl Microbiol Biotechnol (2014) 0.77
Associations between the Rho kinase-1 catalytic and PH domain regulatory unit. J Mol Graph Model (2013) 0.76
Pharmacophore-based virtual screening to aid in the identification of unknown protein function. Chem Biol Drug Des (2012) 0.76
Theoretical studies on the molecular basis of HIV-1RT/NNRTIs interactions. J Enzyme Inhib Med Chem (2010) 0.76
Nucleophile activation in PD...(D/E)xK metallonucleases: an experimental and computational pK(a) study. J Inorg Biochem (2010) 0.76
Classification of the mechanisms of photoinduced electron transfer from aromatic amino acids to the excited flavins in flavoproteins. Phys Chem Chem Phys (2015) 0.76
Molecular dynamics simulations of Factor Xa: insight into conformational transition of its binding subsites. Biopolymers (2008) 0.75
New insights into the binding and catalytic mechanisms of Bacillus thuringiensis lactonase: insights into B. thuringiensis AiiA mechanism. PLoS One (2013) 0.75
Efficient 3D database screening for novel HIV-1 IN inhibitors. J Chem Inf Comput Sci (2004) 0.75
9,10-Dioxoanthracene-1,4-diyl bis-(4-methyl-benzene-sulfonate). Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
Three-dimensional quantitative structure: activity relationship studies on diverse structural classes of HIV-1 integrase inhibitors using CoMFA and CoMSIA. Eur J Med Chem (2006) 0.75
Non-equivalent conformations of D-amino acid oxidase dimer from porcine kidney between the two subunits. Molecular dynamics simulation and photoinduced electron transfer. Phys Chem Chem Phys (2014) 0.75
Structural basis for the temperature-induced transition of D-amino acid oxidase from pig kidney revealed by molecular dynamic simulation and photo-induced electron transfer. Phys Chem Chem Phys (2012) 0.75
Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors. Eur J Med Chem (2008) 0.75
Postprocessing of protein-ligand docking poses using linear response MM-PB/SA: application to Wee1 kinase inhibitors. J Chem Inf Model (2010) 0.75
Use of a hexasubstituted benzene scaffold in the development of multivalent HIV-1 integrase inhibitors. Chem Pharm Bull (Tokyo) (2014) 0.75
Simultaneous analyses of photoinduced electron transfer in the wild type and four single substitution isomers of the FMN binding protein from Desulfovibrio vulgaris, Miyazaki F. Phys Chem Chem Phys (2011) 0.75
Effective discrimination of antimalarial potency of artemisinin compounds based on quantum chemical calculations of their reaction mechanism. Bioorg Med Chem (2006) 0.75
Anti-HIV-1 Integrase Activity and Molecular Docking Study of Compounds from Caesalpinia sappan L. Phytother Res (2015) 0.75
Molecular modeling of enzyme attachment on AFM probes. J Mol Graph Model (2013) 0.75
Quantum mechanical study of photoinduced charge transfer in FMN binding protein. J Phys Chem B (2008) 0.75
A novel structure-based multimode QSAR method affords predictive models for phosphodiesterase inhibitors. J Chem Inf Model (2010) 0.75
Cluster analysis of hydration waters around the active sites of bacterial alanine racemase using a 2-ns MD simulation. Biopolymers (2008) 0.75
Biophysical characteristics of cholera toxin and Escherichia coli heat-labile enterotoxin structure and chemistry lead to differential toxicity. J Phys Chem B (2014) 0.75
Photoinduced electron transfer modeling to simulate flavoprotein fluorescence decay. Methods Mol Biol (2014) 0.75
Anti-HIV-1 integrase activity and molecular docking of compounds from Albizia procera bark. Pharm Biol (2015) 0.75